about
Wild blueberries (Vaccinium myrtillus) alleviate inflammation and hypertension associated with developing obesity in mice fed with a high-fat dietVitamin D and the Promotion of Long-Term Metabolic Health from a Programming PerspectiveIncreased circulating ANG II and TNF-α represents important risk factors in obese saudi adults with hypertension irrespective of diabetic status and BMIVitamin D and adipose tissue-more than storageRelationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity.Structural and biochemical characteristics of various white adipose tissue depots.The activities of lysyl hydroxylase 3 (LH3) regulate the amount and oligomerization status of adiponectin.Elevated blood pressure in adolescent girls: correlation to body size and composition.Eplerenone restores 24-h blood pressure circadian rhythm and reduces advanced glycation end-products in rhesus macaques with spontaneous hypertensive metabolic syndromeMechanisms linking obesity to hypertension.The Kallikrein-Kinin system.Leptin in heart failure.Adipose afferent reflex: sympathetic activation and obesity hypertension.The emerging epidemic of hypertension in Asian children and adolescents.A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention.Association between serum resistin concentration and hypertension: A systematic review and meta-analysisVitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.Inactivation of SPAK kinase reduces body weight gain in mice fed a High-fat diet by improving energy expenditure and insulin sensitivity.
P2860
Q21090573-7D3FE235-6E3B-4024-A29B-E2E87F8F0685Q26769601-F124454F-43C4-4B41-A58F-10FA2A04F808Q28484327-9ED2E453-CB45-4C6A-A488-B8D6D818CFA3Q30364529-150A5B98-4197-4E62-81D0-9DD314404876Q33823038-B0D747FE-8B6B-4FD8-8A38-58A63B85F309Q34245473-50202D40-C10F-4A73-A621-315B9309BA91Q34499898-29067F64-75C5-486E-9FBF-E3F396D866CEQ35905147-905DF667-A3F2-4E09-AAD4-511C888E4C62Q36754659-64178741-E2E3-4184-9AD2-8D83954382F7Q37914949-1E4E367E-4273-4D7F-A749-AA21202D3867Q38056523-C488C9C7-5D23-48A7-BD7E-AF53C11099A3Q38093250-FFE8063D-55CB-438D-9911-66D396DB2F6EQ38151943-68BACE60-F672-4004-B18A-9271580FA1A9Q38258959-0634C0F1-A20E-4BA9-863C-48390FD4AD1DQ38542689-7BB1269B-7F94-4F0A-A5BE-F211483189F0Q38774655-CADBD514-2EEC-4761-8C1D-EC5A83CEA474Q39242378-F1AA4E87-10AF-4470-9DDF-08608833E2F7Q47179983-34924D1A-5350-42F1-B1F6-2C1C14FDCAC4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of adipokines in obesity-associated hypertension.
@en
Role of adipokines in obesity-associated hypertension.
@nl
type
label
Role of adipokines in obesity-associated hypertension.
@en
Role of adipokines in obesity-associated hypertension.
@nl
prefLabel
Role of adipokines in obesity-associated hypertension.
@en
Role of adipokines in obesity-associated hypertension.
@nl
P2093
P1433
P1476
Role of adipokines in obesity-associated hypertension.
@en
P2093
A K Purhonen
K H Herzig
P304
P356
10.1111/J.1748-1716.2010.02171.X
P577
2010-10-01T00:00:00Z